Filing Details
- Accession Number:
- 0001209191-19-015257
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-03-01 20:01:00
- Reporting Period:
- 2019-02-28
- Accepted Time:
- 2019-03-01 20:01:00
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1029142 | Dynavax Technologies Corp | DVAX | Pharmaceutical Preparations (2834) | 330728374 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1352238 | Louis David Johnson | C/O Dynavax Technologies 2929 Seventh Street, Suite 100 Berkeley CA 94710 | Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2019-02-28 | 5,125 | $9.05 | 52,786 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2019-02-28 | 4,687 | $9.03 | 48,099 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-02-28 | 9,703 | $9.03 | 38,396 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-02-28 | 6,375 | $9.03 | 32,021 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | F | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The reporting person is reporting the sale of 5,125 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the delivery of common stock to the reporting person on February 28, 2019.
Billionaire Hedge Funds
